Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma
Status:
Completed
Trial end date:
2021-03-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if an experimental drug, called copanlisib is effective
and safe in treating adult participants with cholangiocarcinoma, when used in combination
with gemcitabine and cisplatin.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute